Analysts at StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “hold” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback